| Issue Date | Title | Author(s) |
| 2024 | Ascorbic acid-containing compound efficacy in ischemic brain damage | Termulaeva, R. M.; Belanov, K. V.; Bunyatyan, N. D.; Pirozhkov, A. S.; Timoshkin, D. E. |
| 2016 | Cardiovascular effects of an arginase II selective inhibitor | Yakushev, V. I.; Pokrovskii, M. V. |
| 2017 | Effect of pharmacological preconditioning with incretinomimetics exenatide and vildagliptin on the survival of ischemic tissues | Tarasova, A. P.; Danilenko, L. M.; Sernov, L. N. |
| 2015 | Human recombinant erythropoietin gradient dosage influence on ischemic and reperfusion liver injury | Alehin, S. A.; Kolmykov, D. I.; Pokrovskii, M. V. |
| 2015 | Ischemia/reperfusion effect on pancreatic volumetrical blood flow velocity | Kolmykov, D. I.; Alehin, S. A. |
| 2017 | Ligand of peripheral imidazoline receptors based on amides of heterocyclic acids C7070: effect on ishemized tissues | Dovgan, A. P. |
| 2015 | Pharmacological protection of the ischemic myocardium by derivatives of 3-(2,2,2-trimethylhydrazinium) propionate and evaluation of their antioxidant activity | Skachilova, S. Y.; Danilenko, L. M.; Kesarev, O. G.; Kochkarov, I. S. |
| 2022 | Remote ischemic preconditioning combined with atorvastatin improves memory after global cerebral ischemia-reperfusion in male rats | Azim Hedayatpour; Maryam Shiasi; Peyman Modarresi; Alieh Bashghareh |
| 2016 | Test-system for estimation of activity of GSK-3 inhibitors as antihypoxants and differentiation of endothelial progenitors in vitro | Burda, Y. E.; Nadezhdin, S. V.; Zubareva, E. V.; Pokrovskii, M. V.; Faitelson, A. V. |
